VERONA PHARMA PLC - ADR (VRNA) Stock Balance Sheet
NASDAQ:VRNA • US9250501064
Current stock price
106.91 USD
+0.12 (+0.11%)
At close:
106.94 USD
+0.03 (+0.03%)
After Hours:
| MRQ (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 438.02M | 399.76M | 271.77M | 227.80M | 148.40M | |||
| Marketable Securities | N/A | N/A | N/A | N/A | N/A | |||
| Receivables | 86.92M | 37.26M | 10.95M | 9.30M | 15.60M | |||
| Inventories | 8.61M | 6.25M | N/A | N/A | N/A | |||
| Other Current Assets | 15.30M | 10.31M | 6.98M | 5.90M | 6.10M | |||
| Total Current Assets | 548.85M | 453.57M | 289.71M | 243.00M | 170.10M | |||
| Non-Current Assets | ||||||||
| PPE Net | 2.56M | 3.15M | 2.87M | 900.00K | 1.00M | |||
| Investments And Advances | 15.00M | 15.00M | 15.00M | 15.00M | 15.00M | |||
| Goodwill | 545.00K | 545.00K | 545.00K | 500.00K | 500.00K | |||
| Intangibles | N/A | N/A | N/A | N/A | N/A | |||
| Other Non-Current Assets | 5.91M | 1.97M | N/A | N/A | N/A | |||
| Total Non-Current Assets | 24.02M | 20.67M | 18.42M | 16.50M | 16.50M | |||
| TOTAL ASSETS | 572.87M | 474.24M | 308.12M | 259.50M | 186.60M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | N/A | N/A | N/A | N/A | |||
| Accrued Expenses | 44.34M | 17.88M | 4.76M | 14.40M | 22.90M | |||
| Accounts Payable | 3.43M | 11.27M | 3.49M | 2.90M | 10.00M | |||
| Other Current Liabilities | 3.46M | 13.54M | 435.00K | 1.70M | 500.00K | |||
| Total Current Liabilities | 51.24M | 42.68M | 8.69M | 19.00M | 33.40M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 242.43M | 120.34M | 48.37M | 9.80M | 4.90M | |||
| Other Non-Current Liabilities | 926.00K | 106.66M | 1.77M | 200.00K | 300.00K | |||
| Total Non-Current Liabilities | 243.36M | 227.00M | 50.15M | 10.00M | 5.20M | |||
| TOTAL LIABILITIES | 294.60M | 269.68M | 58.84M | 29.00M | 38.60M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -567.10M | -562.40M | -388.43M | -333.10M | -263.70M | |||
| Additional Paid In Capital | 805.92M | 728.20M | 601.06M | 529.20M | 385.10M | |||
| Common Shares | 45.02M | 45.02M | 42.77M | 40.50M | 31.90M | |||
| Treasury Stock | -964.00K | -1.66M | -1.52M | -1.50M | -600.00K | |||
| Other Shareholders' Equity | -4.60M | -4.60M | -4.60M | -4.60M | -4.60M | |||
| Shares Outstanding | N/A | 80.05M | 76.10M | 71.69M | 56.77M | |||
| Tangible Book Value per Share | 277.73 | 0.30 | 0.39 | 0.38 | 0.31 | |||
| Total Shareholders' Equity | 278.27M | 204.56M | 249.28M | 230.50M | 148.00M | |||
| TOTAL LIABILITIES AND EQUITY | 572.87M | 474.24M | 308.12M | 259.50M | 186.60M | |||
| Statistics | ||||||||
| Debt/Equity | 0.87 | 0.59 | 0.19 | 0.04 | 0.03 | |||
| Current Ratio | 10.71 | 10.63 | 33.33 | 12.79 | 5.09 | |||
| Return On Assets (ROA) | -14.17% | -36.57% | -17.65% | -26.47% | -29.78% | |||
| Return On Equity (ROE) | -29.18% | -84.78% | -21.81% | -29.80% | -37.55% | |||
All data in USD , ROIC based on taxRate of 0.21